KalVista Pharmaceuticals (KALV) announced that Brian Piekos has joined the company as CFO. Piekos has more than 25 years of financial and strategic planning experience in the biopharmaceutical industry. He joins KalVista from Elicio Therapeutics (ELTX) where he served as CFO and was responsible for launching Elicio as a public company.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener